Cargando…
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer
Advanced prostate cancer patients initially respond to hormone therapy, be it in the form of androgen deprivation therapy or second-generation hormone therapies, such as abiraterone acetate or enzalutamide. However, most men with prostate cancer eventually develop hormone therapy resistance. This re...
Autores principales: | Jindal, Rashi, Nanda, Abheepsa, Pillai, Maalavika, Ware, Kathryn E., Singh, Divyoj, Sehgal, Manas, Armstrong, Andrew J., Somarelli, Jason A., Jolly, Mohit Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957767/ https://www.ncbi.nlm.nih.gov/pubmed/36851919 http://dx.doi.org/10.1016/j.csbj.2023.01.031 |
Ejemplares similares
-
EMT and MET: necessary or permissive for metastasis?
por: Jolly, Mohit Kumar, et al.
Publicado: (2017) -
Coupled Feedback Loops Involving PAGE4, EMT and Notch Signaling Can Give Rise to Non-Genetic Heterogeneity in Prostate Cancer Cells
por: Singh, Divyoj, et al.
Publicado: (2021) -
Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma
por: Pillai, Maalavika, et al.
Publicado: (2021) -
Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis
por: Pillai, Maalavika, et al.
Publicado: (2022) -
Quantitative landscapes reveal trajectories of cell-state transitions associated with drug resistance in melanoma
por: Pillai, Maalavika, et al.
Publicado: (2022)